Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2007
by National Cancer Institute (NCI).
Recruitment status was Active, not recruiting
Study NCT00002947 Information provided by National Cancer Institute (NCI)
First Received on November 1, 1999. Last Updated on April 26, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gastrointestinal Carcinoid Tumor
Head and Neck Cancer
Intraocular Melanoma
Islet Cell Tumor
Kidney Cancer
Lung Cancer
Melanoma (Skin)
Neoplastic Syndrome
Pheochromocytoma
Additional conditions recognized in this trial
Adenoma, Islet Cell
Carcinoid Tumor
Carcinoma
Carcinoma, Basal Cell
Carcinoma, Basosquamous
Carcinoma, Merkel Cell
Carcinoma, Neuroendocrine
Carcinoma, Renal Cell
Carcinoma, Squamous Cell
Central Nervous System Neoplasms
Gastrointestinal Neoplasms
Head and Neck Neoplasms
Histiocytosis
Histiocytosis, Langerhans-Cell
Kidney Neoplasms
Lung Neoplasms
Malignant Carcinoid Syndrome
Melanoma
Neoplasms
Nervous System Neoplasms
Skin Neoplasms
Uveal Neoplasms
More general conditions related to this trial
Adenocarcinoma
Adenoma
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Eye Diseases
Eye Neoplasms
Gastrointestinal Diseases
Kidney Diseases
Lung Diseases
Lung Diseases, Interstitial
Lymphatic Diseases
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Basal Cell
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Squamous Cell
Nervous System Diseases
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Pancreatic Diseases
Pancreatic Neoplasms
Paraganglioma
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Skin Diseases
Thoracic Neoplasms
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Uveal Diseases
Interventions listed in this trial
indium In 111 pentetreotide
Sponsors listed in this trial
Yale University
National Cancer Institute (NCI)
Back to top of Main Content